New cDAT application for for automated quantification of DAT SPECT images further extends Combinostics’ solutions across the entire patient pathway for neurological disorders and supports end-to-to-end workflows
Attending RSNA 2022? Stop by booth 3938 in the AI Showcase to learn about our complete solution for early detection, diagnosis, and management of neurological disorders.
New cPET application for amyloid and FDG brain PET quantification further extends Combinostics’ solutions across the entire patient pathway for neurological disorders and supports end-to-to-end workflows.
New cPET application for amyloid and FDG brain PET quantification further extends Combinostics’ solutions across the entire patient pathway for neurological disorders and supports end-to-to-end workflows
Attending ASNR 2023? Stop by booth 603 to learn about our complete solution for the early detection, diagnosis, and management of neurological disorders.
Attending ASNR 2023? Stop by booth 603 to learn about our complete solution for the early detection, diagnosis, and management of neurological disorders.
Stockholm, 14 June 2023 – Today, partners of the PROMINENT project announced the launch of…
Visit us at booth Süd 36 at the 104th German X-ray Congress (RÖKO2023) to learn more about our complete solution for the early detection, diagnosis, and management of neurological disorders.
We recently spoke with Kevin Berger, MD, from Chesapeake Medical Imaging about his history in neuroradiology, how he’s seen imaging quantification progress over the years, and the benefits he sees from tools such as cMRI.
Attending Advanced MRI? Stop by booth 4 to learn about our complete solution for the early detection, diagnosis, and management of neurological disorders.
Combinostics US Inc.
177 Huntington Ave
17th Floor
Boston, MA 02115, USA
© Combinostics | Privacy Policy
